Enterprise Solutions Webinars
-
Expanding The OSD Toolbox
10/3/2024
This session is designed to provide practical solutions for enhancing bioavailability and scalability in pharmaceutical formulations.
-
Understanding Nitrosamines: Key Regulations And Best Practices
10/2/2024
Gain expert insights into nitrosamine regulations and discover practical strategies for ensuring compliance and safeguarding product safety.
-
Understanding FDA Calibration Requirements And Best Practices For Reducing Risks
10/2/2024
Become equipped with the tools and strategies needed to strengthen your calibration efforts and better position your organization for success in regulatory audits.
-
What Do You Need To Qualify A Single-Use Assembly?
10/2/2024
Explore best practices for the qualification of single-use systems, focusing on quality and regulatory documentation.
-
Extractables And Leachables: Setting Up Early For Success With Your CDMO
10/2/2024
Discover insights tailored specifically for drug product researchers and manufacturers, offering key knowledge on extractables, leachables, and effective implementation strategies.
-
Strategic Antibody Outsourcing: Guidance On Selection, Services, And Facility Fit
9/24/2024
How do you choose the best CDMO for your program? In this presentation, experts share insights and best practices on selecting, qualifying, and managing CDMO partnerships.
-
MicroCNX® Series Connectors: Introducing The MicroCNX ULT And MicroCNX Luer
9/23/2024
Experience the future of connectivity. Designed for enhanced simplicity and productivity, these innovative connectors are perfect for cell therapies requiring cryogenic freezing and sterile connections.
-
Formulation And Process Development For High-Concentration Subcutaneous Biologics Drug Product
9/20/2024
Delve into the specific challenges encountered in the development of high-concentration formulations and gain an overview of current state-of-the-art solutions for subcutaneous administration.
-
Navigating Challenges In Biologics Process Development And Characterization
9/18/2024
Delve into the key obstacles encountered in biologics process development, including the complexities of optimizing production processes, ensuring product consistency, and maintaining quality control.
-
Manufacture To Control: Considerations In CMC For Antibody-Drug Conjugates
9/18/2024
The complex nature of ADCs necessitates meticulous attention to CMC. Gain valuable insights for navigating CMC development, ensuring the delivery of safe and efficacious biopharmaceutical products.